Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor. (December 2018)

• Record Type: Journal Article
• Authors: Suno, Ryoji; Lee, Sangbae; Maeda, Shoji; Yasuda, Satoshi; Yamashita, Keitaro; Hirata, Kunio; Horita, Shoichiro; Tawaramoto, Maki; Tsujimoto, Hirokazu; Murata, Takeshi; Kinoshita, Masahiro; Yamamoto, Masaki; Kobilka, Brian; Vaidehi, Nagarajan; Iwata, So; Kobayashi, Takuya
• Is Part Of: Nature chemical biology. Volume 14:Number 12(2018)
• Page Start: 1150
• Page End: 1158
• Publication Date: 2018-12
• Subjects: Biochemistry -- Periodicals; Biochimie -- Périodiques; 572.05
• DOI: 10.1038/s41589-018-0152-y
• Languages: English
• ISSNs: 1552-4450

Abstract

Abstract Human muscarinic receptor M2 is one of the five subtypes of muscarinic receptors belonging to the family of G-protein-coupled receptors. Muscarinic receptors are targets for multiple neurodegenerative diseases. The challenge has been designing subtype-selective ligands against one of the five muscarinic receptors. We report high-resolution structures of a thermostabilized mutant M2 receptor bound to a subtype-selective antagonist AF-DX 384 and a nonselective antagonist NMS. The thermostabilizing mutation S110R in M2 was predicted using a theoretical strategy previously developed in our group. Comparison of the crystal structures and pharmacological properties of the M2 receptor shows that the Arg in the S110R mutant mimics the stabilizing role of the sodium cation, which is known to allosterically stabilize inactive state(s) of class A GPCRs. Molecular dynamics simulations reveal that tightening of the ligand–residue contacts in M2 receptors compared to M3 receptors leads to subtype selectivity of AF-DX 384. A structural study supported by molecular dynamics simulations describes the basis of receptor-subtype selectivity of a small-molecule antagonist of the human muscarinic M2 receptor.